An open position for a Research Engineer in Cell-Free _expression_ of Therapeutic mAbs is open at IBS, Grenoble, France. In collaboration with Sanofi, the IBS NMR group is developing innovative tools for therapeutic mAbs characterization based on the efficient and complementary NMR-based and advanced isotopic labeling methods. The consortium is seeking to reinforce the team and is recruiting a research engineer who will be in charge of the development, optimization and application of cell-free approaches for the large scale production of isotopically labeled Fab domains of therapeutic mAbs.
Candidates should hold a PhD in Biology/Biochemistry/Structural Biology or an Engineer degree in Biology/Biochemistry/Chemistry + 3 years of experience in protein biochemistry. Interested candidates should send a CV with a publication list, a cover letter and the names and emails of two references. These documents must be submitted via email to email@example.com before January 22nd 2023. The preselected candidates will be contacted to be interviewed end of January. The expected starting date is March 1st 2023 and contract will last until July 31st 2024.
For more details please go to : https://www.ibs.fr/IMG/pdf/offre-research-engineer_nmr_2023_1er_semestre.pdf